RNTX·00887A204·US·equity·Healthcare - Biotechnology-13D/G
RNTX (REIN THERAPEUTICS INC) is held by 21 institutional investors as of Q4 2025. Largest holders: NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO ($55,172), HighTower Advisors, LLC ($13,000), UBS Group AG ($1,331). Net institutional sentiment: Bullish.
See how RNTX's score breaks down across 4 SEC sources
Showing 3 of 21 results.18 more with Pro.PROUpgrade to see all → |
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer